Art of Manufacturing: Vaccines, Antibiotics, and Antimicrobials

San Francisco, More than 50,000 people die in the U.S each year from diseases that could have been prevented with a simple vaccine. Influenza is by far the biggest killer, but there are also regular outbreaks of measles, meningitis, and pertussis. Ebola virus and Pertussis (or whooping cough) is currently epidemic in California. Unvaccinated people can spread disease to other adults and the children too young to be immunized. These are the some of the Global market research analysis for Vaccines approved by BCC. Global revenue for vaccine technologies was nearly $31.8 billion in 2011. This market is expected to increase from $33.6 billion in 2012 to $43.4 billion in 2017, for DNA vaccines was valued at $305.3 million in 2014, and further to $2.7 billion by 2019, influenza market will grow from nearly $6 billion in 2018. The protein therapeutics market is expected to decline to $136.7 billion in 2013 and then increase to nearly $179.1 billion in 2018, for Multiple Sclerosis (MS) disease-modifying products is expected to grow to nearly $14.2 billion in 2018. The global protein therapeutics market is expected to decline to $136.7 billion in 2013 and then increase to nearly $179.1 billion in 2018, a compound annual growth rate (CAGR) of 5.6% over the five-year period from 2013 to 2018.
  • Broad spectrum antibiotics and current development
  • Fungal infections and anti-fungal therapeutics
  • Antiviral drugs and viral resistance
  • Mycotoxins and phycotoxins
  • Antiretroviral therapy and current research on HIV/AIDS
  • Advancements in pharmaceutical microbiology
  • Antimicrobial Pharmacokinetic and Pharmacodynamic modelling and simulation
  • Nanopatches and nanovaccination
  • Natural vs. synthetic antimicrobials
  • Bacteriocins and their significance
  • Anti-microbial coatings
  • Clinical disinfectants
  • Plant and animal based vaccines
  • Rotavirus and Pneumococcal vaccines
  • Food safety and glyco-conjugate vaccines
  • Antiviral and antibacterial vaccines
  • Synthetic vitamins, nutraceuticals and functional foods
  • Broad spectrum antibiotics and current development
  • Broad spectrum antibiotics and current development
  • Fungal infections and anti-fungal therapeutics

Related Conference of Art of Manufacturing: Vaccines, Antibiotics, and Antimicrobials

Art of Manufacturing: Vaccines, Antibiotics, and Antimicrobials Conference Speakers